Diagnostic predictive value of the Bladder EpiCheck test in the follow‐up of patients with non–muscle‐invasive bladder cancer

Emanuela Trenti, Carolina D’Elia, Christine Mian, +8

Cancer Cytopathology

Comparison of 2 new real‐time polymerase chain reaction–based urinary markers in the follow‐up of patients with non–muscle‐invasive bladder cancer

Emanuela Trenti, Stefan Pycha, Christine Mian, +8

Cancer Cytopathology

Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer

Mona Kafka, Fabian Mayr, Veronika Temml, +11

Cancers

Dual Inhibitory ActionNovel Akr1c3 InhibitorUrologyAndrogen ReceptorEnzalutamide Resistance +12

Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study

Mona Kafka, Andreas Horninger, Gianpaolo di Santo, +27

European Urology Oncology

Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa

Burkhard H.A. von Rahden, Stefan Kircher, Mona Kafka, +5

Cancer Biomarkers

PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer

Thomas Steuber, Isabel Heidegger, Mona Kafka, +13

European Urology Oncology

UrologyOncologyGenitourinary CancerMedicineReal-life Prospective Study +5

Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study

Mona Kafka, Giulia Giannini, Nastasiia Artamonova, +34

Clinical Genitourinary Cancer

Organ-Sparing Surgery in Testicular Tumor: Is This the Right Approach for Lesions ≤ 20 mm?

Nina Staudacher, Gennadi Tulchiner, Katie Bates, +5

Journal of Clinical Medicine

Diagnostic value of Xpert^® Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update

Carolina D’Elia, D.M. Folchini, Christine Mian, +9

Therapeutic Advances in Urology

Xpert® bladder cancer detection as a diagnostic tool in upper urinary tract urothelial carcinoma: preliminary results

Carolina D’Elia, Emanuela Trenti, Philipp Krause, +9

Therapeutic Advances in Urology